BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
senores pharmaceuticals limite stock

SENORES PHARMACEUTICALS LIMITE Share Price

515 -25.29 (-4.68%)
14 Feb 2025 | 03:30 PM Pharmaceuticals NSE: SENORES

SENORES PHARMACEUTICALS LIMITE Share Price Update

As of the latest trading session, SENORES PHARMACEUTICALS LIMITE share price is currently at 515, which is down by -25.29 from its previous closing. Today, the stock has fluctuated between 498.90 and 552.00. Over the past year, SENORES PHARMACEUTICALS LIMITE has achieved a return of 0.00 %. In the last month alone, the return has been 10.81 %. Read More...

SENORES PHARMACEUTICALS LIMITE Performance

Day Range

Low498.90 High552.00
515.00

52 Week Range

Low 435.25 High 644.80
515.00

SENORES PHARMACEUTICALS LIMITE Share Price

28888

544319

SENORES

img img img img
No Data Available

Open Price

543.95

Prev. Close

540.30

Volume (Shares)

987032.00

Total traded value

5083.21

Upper Circuit

648.35

Lower Circuit

432.25

Note: The current prices & values are delayed, Login to your account for live updates.

SENORES PHARMACEUTICALS LIMITE Fundamentals


(Standalone)

Market Cap (Cr) 1570.98
PE Ratio (TTM) 2853.61
Book Value / Share 159.10
Beta 3.10
ROE 0.78%
EPS (TTM) 0.18
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.07

SENORES PHARMACEUTICALS LIMITE Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 9.59
Operating Expense 15.46
Net Profit 1.07
Net Profit Margin (%) 11.15
Earnings Per Share (EPS) 0.32
EBITDA 4.77
Effective Tax Rate (%) 18.93
Particulars MAR 2024 (Values in Cr)
Revenue 9.45
Operating Expense 0.00
Net Profit 0.34
Net Profit Margin (%) 3.59
Earnings Per Share (EPS) 0.11
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 8.91
Operating Expense 10.57
Net Profit 0.20
Net Profit Margin (%) 2.24
Earnings Per Share (EPS) 0.08
EBITDA 1.62
Effective Tax Rate (%) 59.18
Particulars MAR 2024 (Values in Cr)
Revenue 34.01
Operating Expense 38.83
Net Profit 0.81
Net Profit Margin (%) 2.38
Earnings Per Share (EPS) 0.35
EBITDA 6.78
Effective Tax Rate (%) 60.09
Particulars MAR 2023 (Values in Cr)
Revenue 12.38
Operating Expense 17.23
Net Profit 1.20
Net Profit Margin (%) 9.69
Earnings Per Share (EPS) 1.26
EBITDA 5.01
Effective Tax Rate (%) 38.14
Particulars MAR 2022 (Values in Cr)
Revenue 15.85
Operating Expense 15.98
Net Profit 0.29
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.33
EBITDA 1.97
Effective Tax Rate (%) 67.77
Particulars MAR 2021 (Values in Cr)
Revenue 7.91
Operating Expense 7.66
Net Profit 0.84
Net Profit Margin (%) 10.61
Earnings Per Share (EPS) 2.20
EBITDA 1.17
Effective Tax Rate (%) -109.99
Particulars MAR 2024 (Values in Cr)
Book Value / Share 66.96
ROE % 26.19
ROCE % 12.04
Total Debt to Total Equity 1.28
EBITDA Margin 20.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 46.36
ROE % 20.54
ROCE % 18.24
Total Debt to Total Equity 0.94
EBITDA Margin 46.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.86
ROE % 2.71
ROCE % 3.33
Total Debt to Total Equity 0.40
EBITDA Margin 17.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.11
ROE % 0.78
ROCE % 2.56
Total Debt to Total Equity 0.76
EBITDA Margin 19.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.66
ROE % 3.30
ROCE % 5.44
Total Debt to Total Equity 1.06
EBITDA Margin 40.47
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.54
ROE % 3.15
ROCE % 4.51
Total Debt to Total Equity 0.43
EBITDA Margin 15.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 24.91
ROE % 8.87
ROCE % 4.55
Total Debt to Total Equity 0.39
EBITDA Margin 14.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.05
Total Assets 621.88
Total Liabilities 621.88
Total Equity 231.71
Share Outstanding 30504615
Price to Book Ratio 0.00
Return on Assets (%) 5.05
Return on Capital (%) 6.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 131.05
Total Liabilities 131.05
Total Equity 45.49
Share Outstanding 9815000
Price to Book Ratio 0.00
Return on Assets (%) 6.43
Return on Capital (%) 7.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.21
Total Assets 59.15
Total Liabilities 59.15
Total Equity 36.59
Share Outstanding 9815000
Price to Book Ratio 0.00
Return on Assets (%) 1.67
Return on Capital (%) 1.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.44
Total Assets 285.85
Total Liabilities 285.85
Total Equity 168.11
Share Outstanding 30504615
Price to Book Ratio 0.00
Return on Assets (%) 0.28
Return on Capital (%) 0.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 102.62
Total Liabilities 102.62
Total Equity 38.19
Share Outstanding 9815000
Price to Book Ratio 0.00
Return on Assets (%) 1.78
Return on Capital (%) 1.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 55.16
Total Liabilities 55.16
Total Equity 33.69
Share Outstanding 7133000
Price to Book Ratio 0.00
Return on Assets (%) 1.23
Return on Capital (%) 1.42
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 14.95
Total Liabilities 14.95
Total Equity 9.46
Share Outstanding 3800000
Price to Book Ratio 0.00
Return on Assets (%) 5.58
Return on Capital (%) 6.35
Particulars MAR 2024 (Values in Cr)
Net Income 24.94
Cash from Operations -11.86
Cash from Investing -54.65
Cash from Financing 86.98
Net change in Cash 12.45
Free Cash Flow 39.96
Particulars MAR 2023 (Values in Cr)
Net Income 12.43
Cash from Operations 0.37
Cash from Investing -48.28
Cash from Financing 46.25
Net change in Cash -3.11
Free Cash Flow 47.65
Particulars MAR 2022 (Values in Cr)
Net Income 1.14
Cash from Operations -10.30
Cash from Investing -24.44
Cash from Financing 36.46
Net change in Cash 1.57
Free Cash Flow 0.37
Particulars MAR 2024 (Values in Cr)
Net Income 2.03
Cash from Operations -55.87
Cash from Investing -13.50
Cash from Financing 86.67
Net change in Cash 10.34
Free Cash Flow -36.61
Particulars MAR 2023 (Values in Cr)
Net Income 2.58
Cash from Operations -47.31
Cash from Investing 1.07
Cash from Financing 45.33
Net change in Cash -1.37
Free Cash Flow -46.96
Particulars MAR 2022 (Values in Cr)
Net Income 0.83
Cash from Operations -23.91
Cash from Investing -10.05
Cash from Financing 33.87
Net change in Cash -0.23
Free Cash Flow -23.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.40
Cash from Operations -2.85
Cash from Investing -4.37
Cash from Financing 8.49
Net change in Cash 1.25
Free Cash Flow -0.06
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 27.82 2.64 370.98 39.20 / 77.70
BLISS GVS PHARMA LTD 132.25 17.33 1.37 1393.52 92.25 / 184.95
CIPLA LTD 1459.05 23.62 4.15 117834.93 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 298.95 24.77 3.03 879.84 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 42.10 8.23 370.98 39.20 / 77.70
AMRUTAJAN HEALTH LTD 612.45 35.90 5.94 1770.63 591.10 / 861.40
ASTRAZENECA PHARMA IND LT 7096.35 105.84 26.11 17740.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 132.25 17.18 1.36 1393.52 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 532.50
  • 26 Days 536.00
  • 10 Days 537.30
  • 50 Days 532.90
  • 12 Days 537.70
  • 100 Days 532.90
  • 20 Days 536.90
  • 200 Days 532.90
542.12
PIVOT
First Resistance 554.13
Second Resistance 567.97
Third Resistance 579.98
First Support 528.28
Second Support 516.27
Third Support 502.43
RSI 45.48
MACD 1.63
Commodity Channel Index (CCI) -48.10
ADX 8.96
Williams % R -88.97

Over 1 Month

down

10.81

Over 3 Months

down

-7.54

Over 6 Months

down

0.00

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

SENORES PHARMACEUTICALS LIMITE Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SENORES PHARMACEUTICALS LIMITE Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
38.2
Promoter Holdings
45.76
FII
4.25
DII
11.78
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Swapnil Jatin Shah Shareholding of Promoter and Promoter Group 3553531.0 7.72
Ashokbhai Vijaysinh Barot Shareholding of Promoter and Promoter Group 3427780.0 7.44
Remus Pharmaceuticals Limited Shareholding of Promoter and Promoter Group 3261744.0 7.08
Renosen Pharmaceuticals Private Limited Shareholding of Promoter and Promoter Group 2694219.0 5.85
Anar Swapnil Shah Shareholding of Promoter and Promoter Group 2294500.0 4.98
Aviraj Overseas Llc Shareholding of Promoter and Promoter Group 1895190.0 4.12
Sangeeta Mukur Barot Shareholding of Promoter and Promoter Group 1042955.0 2.26
Aviraj Group Llc Shareholding of Promoter and Promoter Group 684750.0 1.49
Espee Therapeutics Llp Shareholding of Promoter and Promoter Group 495000.0 1.07
Jitendra Babulal Sanghvi Shareholding of Promoter and Promoter Group 488516.0 1.06
Mukur Yogeshkumar Barot Shareholding of Promoter and Promoter Group 456825.0 0.99
Dhananjay Ashokkumar Barot Shareholding of Promoter and Promoter Group 330000.0 0.72
Shantaben Babulal Sanghvi Shareholding of Promoter and Promoter Group 328569.0 0.71
Hemant Ishwarlal Modi Shareholding of Promoter and Promoter Group 62000.0 0.13
Jatin Siddharthbhai Shah Shareholding of Promoter and Promoter Group 30000.0 0.07
Pinky Jatin Shah Shareholding of Promoter and Promoter Group 30500.0 0.07
Ami Hemantbhai Modi Shareholding of Promoter and Promoter Group 0.0 0.0
Nirmala Brahmbhatt Shareholding of Promoter and Promoter Group 0.0 0.0
Sonal H Rao Shareholding of Promoter and Promoter Group 0.0 0.0
Vasantiben V Brahmbhatt Shareholding of Promoter and Promoter Group 0.0 0.0
Sanghavi Pavankumar Mishrimalji Huf Public Shareholding 507936.0 0.0
Ratnamani Marketing Private Limited Public Shareholding 838095.0 0.0
Jayanti Mishrimal Sanghvi Public Shareholding 666663.0 0.0
Jigar Prakash Sanghvi Public Shareholding 549523.0 0.0
Manoj Prakash Sanghvi Public Shareholding 866984.0 0.0
Prakash Mishrimal Sanghvi Public Shareholding 476190.0 0.0
Aditya Birla Sun Life Insurance Company Limited Public Shareholding 1295538.0 0.0
Icici Prudential Equity Savings Fund Public Shareholding 1278738.0 0.0
Bank Of India Mid & Small Cap Equity & Debt Fund Public Shareholding 511480.0 0.0
Mahindra Manulife Large & Mid Cap Fund Public Shareholding 509162.0 0.0
Suhana Ventures Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Remus Pharmaceuticals Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Psyllium Labs Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Espee Pharma Canada Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Espee Pharma Uk Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Aone Investments Management Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Ssas Family Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Svar Family Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Swapnil Shah Family Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Esdee Enterprise Shareholding of Promoter and Promoter Group 0.0 0.0
Salvino Biosciences Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Espee Drugs & Finechem Co. Shareholding of Promoter and Promoter Group 0.0 0.0
Gliesse Pharmaceuticals Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Healthy Life Nutraceuticals Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Espee Lifesciences Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Espee International Finechempharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Relius Lifesciences Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Aelius Projects Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Di Cal Pharma Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Ashwamegh Minerals Shareholding of Promoter and Promoter Group 0.0 0.0
Aps International Shareholding of Promoter and Promoter Group 0.0 0.0
Aviraj Charitable Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Tierra Fertilizer Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Aviraj Ventures Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Swapnil J Shah Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Jatin Siddharthabhai Shah Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Modi Hemantbhai Ishwarlal Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Ashokkumar Vijaysinh Barot Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Sonal Hemant Modi Shareholding of Promoter and Promoter Group 0.0 0.0
Suhana Swapnil Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Vihaan Swapnil Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Darshil Jatinbhai Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Shailesh Brahmbhatt Shareholding of Promoter and Promoter Group 0.0 0.0
Hemagauri Ashokkumar Barot Shareholding of Promoter and Promoter Group 0.0 0.0
Viraj Ashokkumar Barot Shareholding of Promoter and Promoter Group 0.0 0.0
Parul Barot Shareholding of Promoter and Promoter Group 0.0 0.0
Bhavna Barot Shareholding of Promoter and Promoter Group 0.0 0.0
Rajendra Brahmbhatt Shareholding of Promoter and Promoter Group 0.0 0.0

SENORES PHARMACEUTICALS LIMITE

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SENORES PHARMACEUTICALS LIMITE

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SENORES PHARMACEUTICALS LIMITE

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Senores Pharmaceuticals Ltd?

Answer Field

The share price of Senores Pharmaceuticals Ltd for NSE is ₹ 515 and for BSE is ₹ 513.65.

What is the Market Cap of Senores Pharmaceuticals Ltd?

Answer Field

The market cap of Senores Pharmaceuticals Ltd for NSE is ₹ 15,70.98 Cr. and for BSE is ₹ 15,66.87 Cr. as of now.

What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Senores Pharmaceuticals Ltd for NSE is ₹ 644.80 and ₹ 435.25 and for BSE is ₹ 644.40 and ₹ 440.00.

How to Buy Senores Pharmaceuticals Ltd share?

Answer Field

You can trade in Senores Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Senores Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Senores Pharmaceuticals Ltd?

Answer Field

Senores Pharmaceuticals Ltd share price is for NSE ₹ 515 & for BSE ₹ 513.65 as on 14 Feb 2025 | 03:30 PM.

What is the Market Cap of Senores Pharmaceuticals Ltd Share?

Answer Field

The market cap of Senores Pharmaceuticals Ltd for NSE ₹ 15,70.98 & for BSE ₹ 15,66.87 as on 14 Feb 2025 | 03:30 PM.

What is the P/E Ratio of Senores Pharmaceuticals Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM the price-to-earnings (PE) ratio for Senores Pharmaceuticals Ltd share is 2853.61.

What is the PB ratio of Senores Pharmaceuticals Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM, the price-to-book (PB) ratio for Senores Pharmaceuticals Ltd share is 159.10.

How to Buy Senores Pharmaceuticals Ltd Share?

Answer Field

You can trade in Senores Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Senores Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Senores Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Senores Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader